{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:03:37Z","timestamp":1780959817464,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47994-6","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:45:56Z","timestamp":1776350756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The KRT15 and KRT81 complex promotes lenvatinib resistance in thyroid cancer by upregulating DGKB mediated lipid metabolism"],"prefix":"10.1038","volume":"16","author":[{"given":"Yunjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuanqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"47994_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim, H., Devesa, S. S., Sosa, J. A., Check, D. & Kitahara, C. M. Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA 317, 1338\u20131348 (2017).","journal-title":"JAMA"},{"key":"47994_CR2","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/cncr.24416","volume":"115","author":"AY Chen","year":"2009","unstructured":"Chen, A. Y., Jemal, A. & Ward, E. M. Increasing incidence of differentiated thyroid cancer in the United States, 1988\u20132005. Cancer 115, 3801\u20133807 (2009).","journal-title":"Cancer"},{"key":"47994_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1176731","volume":"14","author":"S Hamidi","year":"2023","unstructured":"Hamidi, S. et al. Review article: New treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance. Front. Endocrinol. 14, 1176731 (2023).","journal-title":"Front. Endocrinol."},{"key":"47994_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger, M. et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N. Engl. J. Med. 372, 621\u2013630 (2015).","journal-title":"N. Engl. J. Med."},{"key":"47994_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose, M. S. et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: A randomised, double-blind, phase 3 trial. Lancet 384, 319\u2013328 (2014).","journal-title":"Lancet"},{"key":"47994_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrendo.2014.209","volume":"11","author":"M Santoro","year":"2015","unstructured":"Santoro, M. & Melillo, R. M. Genetics: The genomic landscape of papillary thyroid carcinoma. Nat. Rev. Endocrinol. 11, 133\u2013134 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"47994_CR7","unstructured":"Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014)."},{"key":"47994_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"47994_CR9","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"47994_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: The role of lipid metabolism in cancer. Cell Metab. 31, 62\u201376 (2020).","journal-title":"Cell Metab."},{"key":"47994_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tcb.2020.06.004","volume":"30","author":"S Seetharaman","year":"2020","unstructured":"Seetharaman, S. & Etienne-Manneville, S. Cytoskeletal crosstalk in cell migration. Trends Cell Biol. 30, 720\u2013735 (2020).","journal-title":"Trends Cell Biol."},{"key":"47994_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0955-0674(03)00016-4","volume":"15","author":"TG Bivona","year":"2003","unstructured":"Bivona, T. G. & Philips, M. R. Ras pathway signaling on endomembranes. Curr. Opin. Cell Biol. 15, 136\u2013142 (2003).","journal-title":"Curr. Opin. Cell Biol."},{"key":"47994_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1083\/jcb.200302033","volume":"162","author":"G Du","year":"2003","unstructured":"Du, G. et al. Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs. J. Cell Biol. 162, 305\u2013315 (2003).","journal-title":"J. Cell Biol."},{"key":"47994_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drup.2015.01.001","volume":"19","author":"D Mokady","year":"2015","unstructured":"Mokady, D. & Meiri, D. RhoGTPases\u2014A novel link between cytoskeleton organization and cisplatin resistance. Drug Resist. Updat. 19, 22\u201332 (2015).","journal-title":"Drug Resist. Updat."},{"key":"47994_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103283","volume":"160","author":"A Zottel","year":"2021","unstructured":"Zottel, A., Jov\u010devska, I., \u0160amec, N. & Komel, R. Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: A systematic review. Crit. Rev. Oncol. Hematol. 160, 103283 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"47994_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09676-y","volume":"10","author":"Y Perone","year":"2019","unstructured":"Perone, Y. et al. SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ER\u03b1 breast cancer. Nat. Commun. 10, 2115 (2019).","journal-title":"Nat. Commun."},{"key":"47994_CR17","doi-asserted-by":"publisher","first-page":"eabd6187","DOI":"10.1126\/sciadv.abd6187","volume":"7","author":"AC Laly","year":"2021","unstructured":"Laly, A. C. et al. The keratin network of intermediate filaments regulates keratinocyte rigidity sensing and nuclear mechanotransduction. Sci. Adv. 7, eabd6187 (2021).","journal-title":"Sci. Adv."},{"key":"47994_CR18","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1016\/j.csbj.2023.07.035","volume":"21","author":"D Mielecki","year":"2023","unstructured":"Mielecki, D. et al. Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing. Comput. Struct. Biotechnol. J. 21, 3810\u20133826 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"47994_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03121-5","volume":"5","author":"RY Nguyen","year":"2022","unstructured":"Nguyen, R. Y. et al. Cytoskeletal dynamics regulates stromal invasion behavior of distinct liver cancer subtypes. Commun. Biol. 5, 202 (2022).","journal-title":"Commun. Biol."},{"key":"47994_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.semcancer.2021.03.017","volume":"81","author":"G Saini","year":"2022","unstructured":"Saini, G. et al. Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer. Semin. Cancer Biol. 81, 220\u2013231 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"47994_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00644-x","volume":"10","author":"AG Casanova","year":"2024","unstructured":"Casanova, A. G. et al. Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis. Cell Discov. 10, 12 (2024).","journal-title":"Cell Discov."},{"key":"47994_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47218-0","volume":"9","author":"DP Hollern","year":"2019","unstructured":"Hollern, D. P. et al. E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration. Sci. Rep. 9, 10718 (2019).","journal-title":"Sci. Rep."},{"key":"47994_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56675-3","volume":"16","author":"V Van den Bossche","year":"2025","unstructured":"Van den Bossche, V. et al. PPAR\u03b1-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma. Nat. Commun. 16, 1237 (2025).","journal-title":"Nat. Commun."},{"key":"47994_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan, Y. et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat. Commun. 13, 4554 (2022).","journal-title":"Nat. Commun."},{"key":"47994_CR25","doi-asserted-by":"publisher","DOI":"10.34133\/2021\/9860123","volume":"2021","author":"HJ Lee","year":"2021","unstructured":"Lee, H. J. et al. Multimodal metabolic imaging reveals pigment reduction and lipid accumulation in metastatic melanoma. BME Front. 2021, 9860123 (2021).","journal-title":"BME Front."},{"key":"47994_CR26","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-024-03092-3","volume":"43","author":"MJ Ma","year":"2024","unstructured":"Ma, M. J. et al. N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene 43, 2405\u20132420 (2024).","journal-title":"Oncogene"},{"key":"47994_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6540","volume":"5","author":"BU Wilke","year":"2014","unstructured":"Wilke, B. U. et al. Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors. Nat. Commun. 5, 5540 (2014).","journal-title":"Nat. Commun."},{"key":"47994_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100880","volume":"4","author":"H Kang","year":"2023","unstructured":"Kang, H. et al. DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Cell Rep. Med. 4, 100880 (2023).","journal-title":"Cell Rep. Med."},{"key":"47994_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.22","volume":"4","author":"P Torres-Ayuso","year":"2015","unstructured":"Torres-Ayuso, P., Tello-Lafoz, M., M\u00e9rida, I. & \u00c1vila-Flores, A. Diacylglycerol kinase-\u03b6 regulates mTORC1 and lipogenic metabolism in cancer cells through SREBP-1. Oncogenesis 4, e164 (2015).","journal-title":"Oncogenesis"},{"key":"47994_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","volume":"83","author":"M Huang","year":"2023","unstructured":"Huang, M. et al. METTL1-mediated m7G tRNA modification promotes Lenvatinib resistance in hepatocellular carcinoma. Cancer Res. 83, 89\u2013102 (2023).","journal-title":"Cancer Res."},{"key":"47994_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"47994_CR32","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"M Kanehisa","year":"2008","unstructured":"Kanehisa, M. et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36, D480-484 (2008).","journal-title":"Nucleic Acids Res."},{"key":"47994_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1471-2164-7-252","volume":"7","author":"I Diboun","year":"2006","unstructured":"Diboun, I., Wernisch, L., Orengo, C. A. & Koltzenburg, M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7, 252 (2006).","journal-title":"BMC Genomics"},{"key":"47994_CR34","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47994-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47994-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47994-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:43:23Z","timestamp":1780958603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47994-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47994"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47994-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethical aspects of this study were reviewed and approved by the REthical approval was granted by the Ethics Committee of Fudan University Shanghai Cancer Center (Approval No: 050432-4-1911D). Research involving human participants was conducted in accordance with the Declaration of Helsinki, and informed consent was obtained from all participants and\/or their legal guardians. All animal experiments were conducted in accordance with the ethical guidelines and regulations for the care and use of laboratory animals. The experimental protocol was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the Experimental Animal Center, Fudan University Shanghai Cancer Center. The study was approved under the ethics approval number: FUSCC-IACUC-S2024-0733, and reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"17725"}}